Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice

Journal of Nutritional Biochemistry

Volumn 27, Issue , 2016, Pages 16-26

  Chaudhry, Kamaljit K ^a   Shukla, Pradeep K ^a   Mir, Hina ^a   Manda, Bhargavi ^a   Gangwar, Ruchika ^a   Yadav, Nikki ^a   McMullen, Megan ^b   Nagy, Laura E ^b   Rao, RadhaKrishna ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adherens junction; Alcohol; Cadherin; Claudin; Occludin; Oxidative stress; Tight junction

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; CADHERIN; CLAUDIN; GLUTAMINE; OCCLUDIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY LIVER; FEMALE; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LIVER INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; TIGHT JUNCTION; ADHERENS JUNCTION; ANIMAL; BODY WEIGHT; C57BL MOUSE; COLON; DRUG EFFECTS; INTESTINE MUCOSA; PATHOPHYSIOLOGY;

ADHERENS JUNCTIONS; ANIMALS; BODY WEIGHT; COLON; ETHANOL; FATTY LIVER; FEMALE; GLUTAMINE; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL;

EID: 84952863354     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.08.012     Document Type: Article

References (45)

1. Anderson C., Andersson T., Molander M. Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 1991, 71:389-393.
2. Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 2009, 50:638-644.
3. Rao R.K., Seth A., Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004, 286:G881-G884.
4. Bode J.C., Bode C., Heidelbach R., Durr H.K., Martini G.A. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984, 31:30-34.
5. Schafer C., Parlesak A., Schutt C., Bode J.C., Bode C. Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol 2002, 37:81-86.
6. Jokelainen K., Reinke L.A., Nanji A.A. Nf-kappab activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease. Cytokine 2001, 16:36-39.
7. Mathurin P., Deng Q.G., Keshavarzian A., Choudhary S., Holmes E.W., Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 2000, 32:1008-1017.
8. Nanji A.A., Su G.L., Laposata M., French S.W. Pathogenesis of alcoholic liver disease--recent advances. Alcohol Clin Exp Res 2002, 26:731-736.
9. Duryee M.J., Klassen L.W., Freeman T.L., Willis M.S., Tuma D.J., Thiele G.M. Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. Alcohol Clin Exp Res 2004, 28:1931-1938.
10. Anderson J.M., Van Itallie C.M. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 2009, 1:1-16. [a002584].
11. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 1994, 127:1617-1626.
12. Rodgers L.S., Fanning A.S. Regulation of epithelial permeability by the actin cytoskeleton. Cytoskeleton (Hoboken) 2011, 68:653-660.
13. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006, 169:1901-1909.
14. Madara J.L. Intestinal absorptive cell tight junctions are linked to cytoskeleton. Am J Physiol 1987, 253:C171-C175.
15. Lilien J., Balsamo J., Arregui C., Xu G. Turn-off, drop-out: functional state switching of cadherins. Dev Dyn 2002, 224:18-29.
16. Gumbiner B., Stevenson B., Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988, 107:1575-1587.
17. Madara J.L., Barenberg D., Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 1986, 102:2125-2136.
18. Wittchen E.S., Haskins J., Stevenson B.R. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem 1999, 274:35179-35185.
19. Jacobi S.K., Odle J. Nutritional factors influencing intestinal health of the neonate. Adv Nutr 2012, 3:687-696.
20. Reeds P.J., Burrin D.G. Glutamine and the bowel. J Nutr 2001, 131:2505S-2508S. [discussion 23S-4S].
21. Evans M.A., Shronts E.P. Intestinal fuels: glutamine, short-chain fatty acids, and dietary fiber. J Am Diet Assoc 1992, 92:1239-1246. [49].
22. Wilmore D.W. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001, 131:2543S-2549S. [discussion 50S-1S].
23. Windle E.M. Glutamine supplementation in critical illness: evidence, recommendations, and implications for clinical practice in burn care. J Burn Care Res 2006, 27:764-772.
24. Feng Y., Ralls M.W., Xiao W., Miyasaka E., Herman R.S., Teitelbaum D.H. Loss of enteral nutrition in a mouse model results in intestinal epithelial barrier dysfunction. Ann N Y Acad Sci 2012, 1258:71-77.
25. Mao Y., Wang S.Q., Mao X.B., Zeng Q.T., Li Y.S. Intestinal barrier function in patients with acute myocardial infarction and the therapeutic effect of glutamine. Int J Cardiol 2011, 146:432-433.
26. Ewaschuk J.B., Murdoch G.K., Johnson I.R., Madsen K.L., Field C.J. Glutamine supplementation improves intestinal barrier function in a weaned piglet model of Escherichia coli infection. Br J Nutr 2011, 106:870-877.
27. Li N., Lewis P., Samuelson D., Liboni K., Neu J. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2004, 287:G726-G733.
28. Basuroy S., Sheth P., Mansbach C.M., Rao R.K. Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Am J Physiol Gastrointest Liver Physiol 2005, 289:G367-G375.
29. Seth A., Basuroy S., Sheth P., Rao R.K. L-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer. Am J Physiol Gastrointest Liver Physiol 2004, 287:G510-G517.
30. Rao R.K., Basuroy S., Rao V.U., Karnaky K.J., Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J 2002, 368:471-481.
31. Basuroy S., Sheth P., Kuppuswamy D., Balasubramanian S., Ray R.M., Rao R.K. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem 2003, 278:11916-11924.
32. Suzuki T., Seth A., Rao R. Role of phospholipase Cgamma-induced activation of protein kinase Cepsilon (PKCepsilon) and PKCbetaI in epidermal growth factor-mediated protection of tight junctions from acetaldehyde in Caco-2 cell monolayers. J Biol Chem 2008, 283:3574-3583.
33. Sheth P., Basuroy S., Li C., Naren A.P., Rao R.K. Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 2003, 278:49239-49245.
34. Iwasaki T., Terrill J., Shavlakadze T., Grounds M.D., Arthur P.G. Visualizing and quantifying oxidized protein thiols in tissue sections: a comparison of dystrophic mdx and normal skeletal mouse muscles. Free Radic Biol Med 2013, 65:1408-1416.
35. Sheth P., Seth A., Atkinson K.J., Gheyi T., Kale G., Giorgianni F., et al. Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Biochem J 2007, 402:291-300.
36. Rao R.K., Li L., Baker R.D., Baker S.S., Gupta A. Glutathione oxidation and PTPase inhibition by hydrogen peroxide in Caco-2 cell monolayer. Am J Physiol Gastrointest Liver Physiol 2000, 279:G332-G340.
37. Rao R. Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 2008, 13:7210-7226.
38. Tremel H., Kienle B., Weilemann L.S., Stehle P., Furst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994, 107:1595-1601.
39. Rao R.K. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol Biol 2008, 447:171-183.
40. Koutroubakis I.E. Recent advances in the management of distal ulcerative colitis. World J Gastrointest Pharmacol Ther 2010, 1:43-50.
41. De Robertis M., Massi E., Poeta M.L., Carotti S., Morini S., Cecchetelli L., et al. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. J Carcinog 2011, 10:9. 10.4103/1477-3163.78279.
42. Martin F.P., Wang Y., Yap I.K., Sprenger N., Lindon J.C., Rezzi S., et al. Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. J Proteome Res 2009, 8:3464-3474.
43. Anderson J.M., Van Itallie C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995, 269:G467-G475.
44. Amores-Sanchez M.I., Medina M.A. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab 1999, 67:100-105.
45. Mates J.M., Perez-Gomez C., Nunez de Castro I., Asenjo M., Marquez J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 2002, 34:439-458.